Sargent Bickham Lagudis’s CME Group CME Stock Holding History

Sargent Bickham Lagudis’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$6.22K	Hold	37	–	–	﹤0.01%	780
2022 Q3	$7K	Sell	37 -13	-26%	-$2.57K	﹤0.01%	740
2022 Q2	$10K	Buy	50 +13	+35%	+$2.76K	﹤0.01%	690
2022 Q1	$9K	Hold	37	–	–	﹤0.01%	724
2021 Q4	$8K	Hold	37	–	–	﹤0.01%	743
2021 Q3	$7K	Hold	37	–	–	﹤0.01%	764
2021 Q2	$8K	Hold	37	–	–	﹤0.01%	739
2021 Q1	$8K	Hold	37	–	–	﹤0.01%	735
2020 Q4	$7K	Hold	37	–	–	﹤0.01%	696
2020 Q3	$6K	Hold	37	–	–	﹤0.01%	637
2020 Q2	$6K	Hold	37	–	–	﹤0.01%	624
2020 Q1	$6K	Sell	37 -31	-46%	-$6.17K	﹤0.01%	619
2019 Q4	$14K	Buy	68 +31	+84%	+$6.36K	﹤0.01%	567
2019 Q3	$8K	Hold	37	–	–	﹤0.01%	588
2019 Q2	$7K	Sell	37 -35	-49%	-$6.45K	﹤0.01%	625
2019 Q1	$12K	Hold	72	–	–	﹤0.01%	582
2018 Q4	$14K	Hold	72	–	–	﹤0.01%	539
2018 Q3	$12K	Hold	72	–	–	﹤0.01%	578
2018 Q2	$12K	Hold	72	–	–	﹤0.01%	556
2018 Q1	$12K	Sell	72 -76	-51%	-$12.1K	﹤0.01%	546
2017 Q4	$22K	Buy	148 +111	+300%	+$15.8K	﹤0.01%	476
2017 Q3	$5K	Hold	37	–	–	﹤0.01%	690
2017 Q2	$5K	Buy	+37	New	+$4.42K	﹤0.01%	651
2016 Q3	–	Sell	-45	Closed	-$4K	–	732
2016 Q2	$4K	Buy	+45	New	+$4.25K	﹤0.01%	623

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Sargent Bickham Lagudis's CME Position: Q4 2022 in Review

Sargent Bickham Lagudis held its CME Group (CME) position steady in Q4 2022 at 37 shares worth $6.22K. The position accounts for ﹤0.01% of the portfolio, ranked #780.

Sargent Bickham Lagudis first reported a position in CME in Q2 2016 and has held it in 24 quarters since. The position peaked at $22K in Q4 2017. 1,149 funds tracked by Wall St. Rank hold CME as of Q4 2022.

Sargent Bickham Lagudis held 37 shares of CME Group worth $6.22K as of Q4 2022.
Sargent Bickham Lagudis left its CME Group share count unchanged in Q4 2022.
CME Group made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #780 holding.
Sargent Bickham Lagudis first reported a position in CME Group in Q2 2016 and has held it in 24 quarters since.
Sargent Bickham Lagudis's CME Group position peaked at $22K in Q4 2017.
1,149 funds tracked by Wall St. Rank held CME Group as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.